Perioperative management and outcomes of hip and knee arthroplasty among heartmate 3 left ventricular assist device recipients
European Journal of Orthopaedic Surgery & Traumatology · 31.03.2026 · 36 (1)
DOI: 10.1007/s00590-026-04692-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 31.03.2026. Verfasst von Oguz Turan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Perioperative Care. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
We aimed to evaluate preoperative cardiovascular assessment, perioperative management, and outcomes in HM3 recipients undergoing hip or knee arthroplasty.
Methods
This retrospective case series included six patients with HM3 LVADs undergoing total hip or knee arthroplasty. Mean age was 67.4 ± 5.7 years; two were female, and two had ischemic cardiomyopathy. Average ejection fraction was 15 ± 4.5%.
Results
Procedures included three knee arthroplasties (50%), two total hip arthroplasties (33.3%), and one hip hemiarthroplasty (16.7%). Median time from LVAD implantation to arthroplasty was 19.2 ± 13.6 months. Patients were admitted an average of 2.7 ± 1.8 days preoperatively; mean postoperative length of stay was 13 days. All patients were anticoagulated with warfarin (mean INR 1.4 ± 0.2), with five requiring heparin bridging. LVAD-related infections developed in three patients (50%), and two (33%) required readmission. At final follow-up, two patients (33%) had died, at a mean of 28 ± 8 months post-arthroplasty and 47 ± 36 months after HM3 implantation.
Conclusion
Hip and knee arthroplasty in HM3 LVAD recipients can be performed with perioperative management strategies that mitigate excess mortality beyond expected LVAD outcomes. These findings highlight the importance of specialized perioperative care in improving the safety and feasibility of arthroplasty in HM3 LVAD patients. Larger studies with longer follow-up are needed to refine patient selection, optimize perioperative care, and clarify the value of arthroplasty in this complex population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, USA.
- Case Western Reserve University, Cleveland, USA.
- Division of Cardiology, Cleveland Clinic, Cleveland, USA.
- Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, USA. piuzzin@ccf.org.
Zitieren
APA
Turan, O., Pasqualini, I., Elmenawi, K. A., Khan, S. T., Nahlawi, R., Alvarez, P., & Piuzzi, N. S. (2026). Perioperative management and outcomes of hip and knee arthroplasty among heartmate 3 left ventricular assist device recipients. European Journal of Orthopaedic Surgery & Traumatology, 36(1). https://doi.org/10.1007/s00590-026-04692-3
Vancouver
Turan O, Pasqualini I, Elmenawi KA, Khan ST, Nahlawi R, Alvarez P, et al. Perioperative management and outcomes of hip and knee arthroplasty among heartmate 3 left ventricular assist device recipients. European Journal of Orthopaedic Surgery & Traumatology. 2026;36(1). doi:10.1007/s00590-026-04692-3
BibTeX
@article{Turan2026,
author = {Turan, Oguz and Pasqualini, Ignacio and Elmenawi, Khaled A and Khan, Shujaa T and Nahlawi, Raya and Alvarez, Paulino and Piuzzi, Nicolas S},
title = {Perioperative management and outcomes of hip and knee arthroplasty among heartmate 3 left ventricular assist device recipients},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2026},
volume = {36},
number = {1},
doi = {10.1007/s00590-026-04692-3}
}
EUVIMED